business

Analyst Reinstates Merck (MRK) with ‘Neutral’ Rating, $125 Price Target

Yahoo Finance · May 12, 2026, 7:01 PM · Also reported by 2 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Truist cuts Insmed stock price target to $185 on competitive risks Investing.com Tigress Financial raises Medline stock price target on AI supply chain shift

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Analyst Reinstates Merck (MRK) with ‘Neutral’ Rating, $125 Price Target

Also covered by

More in business